Digital Biomarker for Asthma
Asthma
Early DevelopmentActive
Key Facts
About electronRx
Digital‑biomarker platform that delivers continuous, AI‑powered insights for respiratory disease drug development.
View full company profileTherapeutic Areas
Other Asthma Drugs
| Drug | Company | Phase |
|---|---|---|
| Technegas® for Asthma | Cyclomedica | Phase 2 |
| Asthma Candidate | Teva | Phase 3 |
| Montelukast Amorphous Form | Morepen Laboratories | Phase-2 |
| Chitinase Inhibitor | Lead Discovery Siena | Discovery |
| RIG-101 | RIGImmune | Pre-clinical |
| SKB378 | Klus Pharma | Phase 1 |
| Asthma Clinical Trials | American Health Research | Not Disclosed |
| Advanced Asthma Products | Polpharma | Not Disclosed |
| Solrikitug | Uniquity Bio | Phase 2 |
| Asthma Trial | Science 37 | Phase 3 |
| CAL-4 | Calyxha Biotechnologies | Preclinical |
| Flutiform | KYORIN Pharmaceutical | Marketed |